F Doll

Summary

Affiliation: CEA Saclay
Country: France

Publications

  1. ncbi Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors
    F Doll
    Departement de Recherche Medicale, Service Hospitalier Frederic Joliot, CEA DSV, 4 Place du General Leclerc, F 91401 Orsay, France
    J Med Chem 42:2251-9. 1999
  2. ncbi Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A
    Frederic Dolle
    Service Hospitalier Frederic Joliot, Departement de Recherche Medicale, CEA DSV, 4 Place du General Leclerc, F 91406 Orsay, France
    Bioorg Med Chem Lett 13:1771-5. 2003

Collaborators

  • Michel Bottlaender
  • Heric Valette
  • Frederic Dolle
  • Christine Coulon
  • Jean-Louis Pinquier
  • Olivier Curet
  • Chantal Fuseau
  • Samir Jegham
  • Jean Louis Pinquier
  • Yann Bramoulle
  • Ilonka Guenther
  • Pascal George
  • Carole Lartizien

Detail Information

Publications2

  1. ncbi Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors
    F Doll
    Departement de Recherche Medicale, Service Hospitalier Frederic Joliot, CEA DSV, 4 Place du General Leclerc, F 91401 Orsay, France
    J Med Chem 42:2251-9. 1999
    ..In the thalamus, a nAChR-rich area, uptake of radioactivity reached a maximum at 60 min (4% I.D./100 mL of tissue). [18F]F-A-85380 appears to be a suitable radioligand for brain imaging nAChRs with PET...
  2. ncbi Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A
    Frederic Dolle
    Service Hospitalier Frederic Joliot, Departement de Recherche Medicale, CEA DSV, 4 Place du General Leclerc, F 91406 Orsay, France
    Bioorg Med Chem Lett 13:1771-5. 2003
    ....